|
|
|
|
| LEADER |
01705nam a2200361 u 4500 |
| 001 |
EB001872124 |
| 003 |
EBX01000000000000001035495 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
190824 r ||| eng |
| 100 |
1 |
|
|a Yeung, Shirley S. T.
|
| 245 |
0 |
0 |
|a Methoxyflurane in pre-hospital settings
|h Elektronische Ressource
|b a review of clinical effectiveness, cost-effectiveness and guidelines
|c Shirley S.T. Yeung, Lorna Adcock
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa
|b CADTH
|c November 9, 2018, 2018
|
| 300 |
|
|
|a 1 PDF file (16 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Anesthetics, Inhalation
|
| 653 |
|
|
|a Methoxyflurane / therapeutic use
|
| 653 |
|
|
|a Wounds and Injuries / drug therapy
|
| 653 |
|
|
|a Methoxyflurane / standards
|
| 653 |
|
|
|a Cost-Benefit Analysis
|
| 653 |
|
|
|a Methoxyflurane / economics
|
| 653 |
|
|
|a Emergency Medical Services / methods
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Acute Pain / drug therapy
|
| 700 |
1 |
|
|a Adcock, Lorna
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK537959
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 330
|
| 520 |
|
|
|a The objective of this review is to evaluate the clinical effectiveness, cost-effectiveness, and evidence-based guidelines for the use of low-dose methoxyflurane for the management of moderate to severe pain associated with trauma or procedures in the pre-hospital setting
|